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Abstract,  Nectadrin, the cell surface glycoprotein rec- 
ognized by the novel mAb 79, was found to be immu- 
nologically identical  to the heat-stable antigen  (HSA). 
It is a  glycoprotein with a polypeptide core of only 30 
amino acids and a very high carbohydrate content 
(Wenger, R.  H., M.  Ayane, R. Bose, G. Kthler,  and 
P. J. Nielsen.  1991.  Eur. J.  lmmunol.  21:1039-1046). 
Immunocytological studies using cultured  splenic 
B-lymphocytes, neuroblastoma cells, and cerebellar 
cells indicated that nectadrin is preferentially expressed 
at sites of cell-cell contact.  Purified nectadrin and 
monoclonal nectadrin antibody 79, but not other 
monoclonal nectadrin antibodies, inhibited the aggre- 
gation of B-lymphocytes by 70%,  suggesting that nec- 
tadrin may act as a cell adhesion molecule. Nectadrin 
was purified from a mouse lymphoma cell line in two 
forms of 40-60 and 23-30 kD. The lower molecular 
weight form appears to be generated from the higher 
molecular weight form by degradative removal of 
saccharide residues characteristic of complex type 
oligosaccharide side chains.  Latex beads coated with 
purified nectadrin aggregated and the rate of their ag- 
gregation depended on the molecular form of necta- 
drin,  with the larger form being more potent than the 
smaller one in mediating bead aggregation.  Nectadrin 
thus appears to be a self-binding cell adhesion mole- 
cule of a structurally novel type in that its extensive 
glycan structures may be implicated in mediating cell 
adhesion. 
T 
HE heat-stable antigen  (HSA), ~ a cell surface glyco- 
protein originally defined by mAb M1/69 (Springer et 
al.,  1978) and later also by mAbs Jlld (Bruce et al., 
1981) and B2A2 (Scollay et al.,  1984),  has attracted much 
interest due to its transient,  developmentally regulated ex- 
pression in many ceils of haematopoietic lineage.  The ex- 
pression of the heat-stable antigen in B-lymphocytes seems 
to correlate with their roles in the immune response: its ex- 
pression is strong in unprimed B-cells and in B-cells that 
differentiate  into antibody-producing  cells but is very weak 
in memory B-cells that have undergone Ig class switching 
(Takei et al.,  1981; Symington and  Hakomori,  1984).  In 
T-cell development, those thymocytes that  are positive for 
CD4 and CD8 strongly express the antigen,  whereas most 
CD4-CD8  +  and  CD4+CD8 -  thymocytes  and  peripheral 
T-lymphocytes show only very weak expression (Takei et al., 
1981; Crispe and Bevan,  1987; Husmann et al., 1988). The 
HSA is also expressed by most myeloid cells and red blood 
cells  throughout  their  development.  However,  monocytes 
cease to express the antigen  upon their differentiation  into 
macrophages and maturing  erythrocytes acquire a distinct 
1, Abbreviations used in this paper: DPBS, Dulbecco's modified PBS; h-nec- 
tadrin, high molecular weight form of nectadrin; HSA, heat-stable antigen; 
l-nectadrin, low molecular weight form of nectadrin; LPS, lipopolysaccha- 
ride from Salmonella  enteritidis;  MAG,  myelin associated  glycoprotein; 
N-CAM, neural cell adhesion molecule. 
form of the antigen,  lower in its molecular weight than that 
of lymphocytes and  immature  monocytes (Miller  et  al., 
1985). The HSA is also expressed in the developing central 
nervous system and by cultured neurones and neuroblastoma 
cells (Rougon et al.,  1991). 
The HSA is a glycoprotein with an extremely small protein 
core, comprising only 30 amino acids,  that in several cell 
types is anchored to the cell membrane via phosphatidylino- 
sitol (Pierres et al., 1987; Alterman et al., 1990; Kay et al., 
1990). Additional genes that would account for larger, trans- 
membranal protein cores have also been described, but these 
forms could not be detected in different tissues and cell lines 
as gene products (Wenger et al., 1991). The apparent molec- 
ular weight of the HSA varies considerably among different 
cell types but also within  each cell type. By Western  blot 
analysis  of lymphoid ceils the antigen  appears  as a broad 
band of 40-68 kD, whereas in mature red blood cells it has 
an apparent  molecular mass of 35-45 kD (Alterman  et al., 
1990) and in embryonic brain it ranges between 28 and 35 
kD (Rougon et al.,  1991). After treatment of the cells with 
tunicamycin  as well as after digestion of the antigen  with 
glycopeptidase F to remove N-linked glycans,  or with 50 
mM NaOH to remove O-linked glycans, the HSA appears by 
SDS-PAGE as two broad bands of ~19 and 23 kD, suggesting 
that it is highly glycosylated and heterogeneous with respect 
to both its N-linked and O-linked  carbohydrates (Alterman 
et al.,  1990; Kay et al.,  1990). 
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HSA in haematopoietic and neural tissues, it has been sug- 
gested that it may be a differentiation antigen involved in the 
regulation  of lymphoid  and  neural  cell development  (Sy- 
mington and Hakomori,  1985; Alterman et al.,  1990; Kay 
et al.,  1990;  Rougon et al.,  1991).  Interestingly,  antibody 
20C9 to the HSA (but not other mAbs to the HSA) inhibits 
the CD3 antibody-mediated activation of CD4 T-cells in the 
presence of lipopolysaccharide (LPS)- activated accessory 
spleen cells (Liu et al., 1992). CD24 has recently been iden- 
tified as the human molecule homologous to the murine HSA 
(Kay et al., 1991). Antibody-mediated cross-linking of CD24 
on the cell surface results in increased free intracellular cal- 
cium levels in B-lymphocytes and in higher peroxide produc- 
tion in granulocytes (Fischer et al.,  1990). CD24 therefore 
appears to be involved in signal transduction. 
In the present study we report that the HSA is a cell adhe- 
sion molecule (CAM) in LPS-activated murine B-lympho- 
blasts.  We further  show that it has  self-binding properties 
which appear to depend on posttranslational  modifications, 
probably in its glycan structures. In view of its unusual car- 
bohydrate content and ability to mediate cell adhesion we 
designated it nectadrin. 
Materials and Methods 
Antibodies 
Immunoafiinity-purified  rabbit polyclonal  antibodies to L1 and neural cell 
adhesion molecule (N-CAM)  and preparation of the IgG fraction have 
been described (Tacke et al., 1987; Kadmon et al., 1990a,b).  mAbs M1/69 
(Springer et al.,  1978; IgG2b), B2A2 (Scollay et al.,  1984; IgM), and Jlld 
(Bruce et al.,  1981; IgM), recognizing  the HSA, were kind gifts from M. 
Simon (Max Planck Institute for Immunobiology,  Freiburg, Germany), H. 
yon Boehmer (Basel Institute for Immunology, Basel, Switzerland),  and M. 
Pierres (Centre of Immunology,  INSERM-CNRS de Marseille, Marseille, 
France), respectively, mAb FD18.5, recognizing the lymphocyte function- 
associated  antigen 1 (LFA-1; Sarmiento et al.,  1982; IgG2a) also was a gift 
from M.  Simon. mAbs 30-H12,  recognizing  Thy-I  (Ledbetter and Herz- 
berg, 1979), and RA3-6C2,  recognizing the B220 antigen of B-lymphocytes 
(Coffman and Weissman, 1981), wore kind gifts from B. Kyewski (The Ger- 
man Cancer Research Centre,  Heidelberg, Germany). mAb 12.15, recog- 
nizing CD2  (Altevogt  et al.,  1988,  1989a;  IgG0  has been described. 
Nonspecific  rat IgG antibodies were purified on a protein G column (Phar- 
macia, Uppsala, Sweden) from sera of nonimmunized adult rats. They in- 
cluded IgGl, IgG2a, and IgG2b isotypes  as tested by enzyme-linked im- 
munosorbent assay (ELISA)  with subelass-specific  antibodies (Dianova, 
Hamburg, Germany) (results  not shown). 
Secondary  antibodies against  rat and rabbit immunoglobolins, conju- 
gated to alkaline phosphatase (Sigma Chemical GmbH, Munich, Germany) 
or to fluorescein isothiocyanate (FITC; Dianova) as well as streptavidin con- 
jugated to fluorescein  isocyothianate  or phycoerythrin (Boehringer Mann- 
heim GmbH, Mannheim, Germany) were purchased from the commercial 
sources. The conjugation of primary antibodies to biotin or FITC was done 
according to Kadmon et al. (1990b). 
Production of  Antibodies to Nectadrin 
mAb 79 to nectadrin (IgG2a; Altevogt et al.,  1988,  1989a) was obtained 
from the fusion of spleen cells from a rat immunized with crude membrane 
preparations from ESb 289 tumor cells (Schirrmacher et al.,  1979,  1982; 
Altevogt r  al., 1988, 1989a). It was purified from the hybridoma superna- 
tant on a Protein G column. Polyclonai  antibodies to nectadrin were ob- 
tained by immunizing a rabbit with biochemically purified  nectadrin (see 
below; Fig.  1) and purification  of the IgG fraction of the antiserum over a 
protein A column (Pharmacia). The immunization procedure followed es- 
tablished protocols (Shiigi and Slomich, 1980), using 100/~g of the purified 
antigen for the initial immunization in complete Freund's adjuvant and for 
each of the following  three boosts  in incomplete Freund's adjuvant.  By 
Western blot analysis, both mAb 79 and the polyclonal antibody recognize 
purified  nectadrin (for mAb 79, see Fig.  6) and, when using crude mem- 
brane preparations from ESb 289 cells, a broad band that comigrates  with 
purified nectadrin (not shown). Both antibodies also recognize the bacterial 
fusion protein of the HSA (Wenger et al.,  1991). 
Antigens 
The isolation of L1 (Rathjen and Schachner,  1984), N-CAM (Thiery et al., 
1977), and the myelin associated glycoprotein  (MAG; Salzer et al.,  1987) 
as integral membrane proteins (designated detergent-soluble  form) has been 
described (Kadmon et al., 1990a). By Western blot analysis, these prepara- 
tions did not contain bands that could be recognized by antibodies to necta- 
drin (not shown).  For coating latex beads, the proteolytic  fragments  con- 
taming the  extracellular  domains of these integral membrane proteins 
(designated  soluble form; Kadmon et al.,  1990a) were used. Recombinant 
CD2 fusion protein containing the two extracellular domains of murine 
CD2 and the constant part of the murine z-light chain produced  in murine 
myeloma cells (Rutschmann and Karjalainen,  1991) was a kind gift from 
R. Rutschmann  (Basel Institute for Immunology,  Basel,  Switzerland). 
Purification of Nectadrin 
Nectadrin was either purified by ion exchange and gel filtration chromatog- 
raphy or by immunoaflinity chromatography using mAb 79. For the former 
(Fig. 1), sucrose density gradient-purified  crude plasma membrane prepara- 
tions (Thinnes et al.,  1984) from ESb 289 cells (10 g wet weight; a kind 
gift of N. Hilschmann, Max Planck Institute for Experimental Medicine, 
G6ttingen, Germany) were solubflized in 50 ml of 10 mM Tris-HC1 buffer, 
pH 8.0, containing 20 mM NaCI,  1 mM phenylmethylsulfonyl  fluoride, and 
2% CHAPS (both from Sigma Chemical GmbH). After centrifugation at 
100,000 g for 1 h, the supernatant was collected  and dialyzed  against the 
same buffer containing 0.2% CHAPS. The supernatant was then applied to 
a Mono Q column (Pharmacia)  and eluted with a 20-1,000 mM NaCI gra- 
dient in this CHAPS-containing buffer. The first protein peak (Fig. 1 A) was 
recovered and dialyzed against 25 mM diethanolamine-HCl, pH 9. 3, 20 ram 
NaC1, and 0.2 % CHAPS. It was then applied to a Mono P column (Pharma- 
cia) and eluted as described for the Mono Q column, but using a 20-500 
mM NaC1 gradient in the latter buffer. The first protein peak (Fig.  1 B), 
containing mAb 79-reactive material, was again recovered, dialyzed against 
10 mM Tris-HC1, pH 8.0, 20 mM NaCI,  and 0.2%  CHAPS, and applied 
to a Superose  6 column (Pharmacia) for size fractionation.  The main pro- 
rein peak eluted (Fig. 1 C) contained purified nectadrin which migrated by 
SDS-PAGE as a broad band of 40-60 kD (Fig.  1 D). 
Immunoaflinity  purification  of nectadrin from sucrose density gradient- 
purified crude plasma membrane preparations (Thinnes et al., 1984) from 
the lymphoma cell line ESb 289 was performed according to Rathjen and 
Schachner (1984) using mAb 79 to nectadrin coupled to Sepharose 4B. 
Nectadrin was eluted from the column with a 0.1 N diethylamine buffer, pH 
11.5, containing 0.1 N NaCI,  1 mM EDTA,  1 mM EGTA,  and 1 mg/nil 
deoxycholic acid (DOC) and was thoroughly dialyzed against 20 mM Tris- 
HC1, pH 8.0, containing 20 mM NaC1 and 1 mg/ml DOC. This preparation 
yielded  a molecular form of nectadrin with a minor broad band of 40-60 
kD and a major broad band of 23-30 kD (see Fig. 6) as seen by SDS-PAGE 
and Western blot analysis  (Towbin et al.,  1979).  The two forms of necta- 
drin, the form purified by ion exchange and gel filtration chromatography, 
with the higher apparent molecular weight,  and the form purified  by im- 
munoattinity chromatography,  predominantly with the lower apparent mo- 
lecular weight,  will be referred to as h-nectadrin and l-nectadrin, respec- 
tively.  No  impurities  were  found  in  the  nectadrin  preparations  by 
SDS-PAGE after staining by the reducing silver method (for h-nectadrin, 
see Fig.  1 D) or by Western blot analysis using polyclonal  antibodies to L1 
or N-CAM or mAb 12.15 to CD2 (not shown). 
Deglycosylation 
To remove  N-linked glycans from nectadrin, nectadrin was precipitated 
with acetone overnight  at 20~  and dissolved in 50 #1 endoglycosidase 
buffer (100 mM Tris-HCl,  pH 8.0, containing 10 mM EDTA, 5 mg/ml SDS, 
and 140 mM 2-mercaptoethanol), and heated for 3 rain to 95~  Nectadrin 
was then incubated overnight at 37~  in the presence of 0.2 U endoglycosi- 
dase F/N-glycopeptidase  F (Boehringer  Mannheim GmbH; Tarentino et al., 
1985) and 1% (vol/vol) Triton X-100 (Sigma Chemical GmbH). The diges- 
tion was terminated on ice and by the addition of electrophoresis sample 
buffer (Laemmli, 1970) and boiling for 3 rain. For control, the enzyme was 
omitted. 
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chromatographic  purification  of  necta- 
drin. (A) ESb 289 cell membrane prepara- 
tions were solubilized  in buffer A, applied 
to a mono Q anion exchange column and 
eluted with a continuous gradient of  buffer 
A to buffer B. The first eluted protein peak 
(marked by a bracket) included nectadrin- 
positive material and was used for further 
purification.  (B)  The  isolated first pro- 
tein peak in A was dialyzed against buffer 
C, applied to a mono P cation exchange 
column and eluted with a continuous gra- 
dient of buffer C  to buffer D.  The first 
eluted protein peak (marked by a bracket) 
again contained nectadrin-positive mate- 
rial and was used for further purification. 
(C) The isolated first protein peak in B 
was dialyzed against buffer E  and sepa- 
rated on a  Superose 6  size fractionation 
column. The major protein peak (marked 
by  a  bracket)  eluted  after  chasing  the 
loaded sample with buffer E  was further 
analyzed. (D) The isolated protein peak 
in C (marked by a bracket)  was tested by 
SDS-PAGE  followed  by  silver  staining 
(silver stain)  and  Western blot analysis 
with mAb 79 (mNec). For control, West- 
ern blot analysis was performed omitting 
the primary antibody (2nd Ab). The posi- 
tions of molecular mass markers are indi- 
cated in kD at the right margin (kD). 
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A mixture of the twe forms of nectadrin as well as the control glycoproteins 
transferrin, fetuin, asialofetuin, and carboxypeptidase Y (all from Boeh- 
ringer Mannbeim GmbH)  were electrophoretically separated and trans- 
ferred to nitrocellulose sheets as for Western blot analysis (see below). The 
ability  of  digoxigenin-labeled  agglutinins  from  Datura  stramonium, 
Maackia amurensis,  Galanthus  nivalis,  Sambucus nigra, Aleuria arantia, 
and  Ulex  europeus  (Glycan Differentiation Kit;  Boehringer Mannbeim 
GmbH) as well as concanavalin A to bind to these proteins was then tested 
according to the instructions of the manufacturer. 
Biosynthetic Carbohydrate  Labeling 
and lmmunoprecipitation 
For biosynthetic labeling with radioactive sugars, 107 ESb 289 cells were 
incubated for 24 h at 37~  in complete RPMI 1640 medium (Boehringer 
Mannheim GmbH) supplemented with 50/~Ci/ml of each 3H-labeled fu- 
cose, glucosamine, and galactose (Amersham Buchler, Braunschweig, Ger- 
many) as previously described (Altevogt et al., 1989a).  The cells were then 
washed and lysed in the presence of 1% Triton X-100. Nectadrin was subse- 
quently immunoprecipitated using a mixture of mAbs 79,  B2A2,  M1/69, 
and Jtld as previously described (Lang et al., 1987).  The immunoprecipi- 
tare was separated electrophoreticaily and examined by autoradiography as 
previously described (Lang et al.,  1987). 
Sodium Dodecylsulfate Polyacrylamide Gel 
Electrophoresis and Western Blot Analysis 
Sodium dodecylsulfate polyacrylamide gel electrophoresis (SDS-PAGE) 
was  performed  in  8,  10,  or  15%  slab  gels  containing an  acrylamide/ 
bisacrylamide ratio of 30:0.8  using the Laemmli buffer system (Laemmli, 
1970).  Western blot analysis was performed according to Towbin et al. 
(1979).  When detergent-solubilized cells were analyzed, the cells were 
homogenized in hypotonic Tris-HCl buffer (10 raM, pH 7.4) containing 1% 
Triton X-100, cleared by centrifogation (100,000 g, 30 rain), and mixed with 
an  equal  volume  of  2x  concentrated  electrophoresis  sample  buffer 
(Laemmli, 1970)  before boiling them for 3 min. 
Cells and Cell Culture 
Spleen cells were obtained from 6-wk-old DBA/2 mice. They were asepti- 
caily removed from their connective tissue capsule with a  bent eanule, 
washed in PBS, pH 7.2  (100 g  for I0 min at 4~  treated with 0.15 M 
NI-I4C1, 0.017  M  Tris-HC1,  pH  7.2,  to  lyse erythrocytes (Misbell and 
Shiigi, 1980), and washed twice again in PBS. They were maintained in tis- 
sue culture flasks in RPMI-1640 medium supplemented with 10% FBS. To 
enrich the primary cultures for B-lymphocytes, B-lymphocytes were se- 
lectively induced to proliferate by the addition of LPS from Salmonella 
enteritidis (50-100 ng/ml; Serva, Heidelberg, Germany) to the cultures for 
2  d  (Morrison and  Ryan,  1979).  For  immunofluorescence microscopy, 
B-tymphocytes were cultured as monolayers on poly-L-lysine-coated  glass 
coverslips  under the same conditions. For cell aggregation assays, LPS-acti- 
vated B-lymphocytes were further purified by Ficoll-Pacque 400 (Phar- 
macia) gradient centrifugation according to the instructions of  the manufac- 
turer. The purity of the cell preparations for B-lymphocytes was examined 
by cytofluorography using mAbs to the B220 antigen (Coffrnan and Weiss- 
man, 198t) and Thy-1 (Ledbetter and Herzberg, 1979) and generally ex- 
ceaded 90%. Thymocytes were obtained from thymus of 6-wk-old DBA/2 
mice as previously described (Altevogt et al., 1989a).  Bone marrow cells 
and erythrocytes were obtained form the tibia (Whitelock et al., 1984) and 
blood of DBA/2 mice, respectively. 
The cell lines, Eb 288 and ESb 289 (T-lymphoma; Schirrmacher et al., 
1979),  EL-4 (T-lymphoma; Culvenor et at., 1981), WEH1267.5 (plasmocy- 
toma; Culvenor et al.,  1981),  18-81 (pre-B-lymphoma; Culvenor et al., 
1981),  P3x63Ag8.653  (plasmocytoma; Kearney et al., 1979),  and BALB/ 
3T3 (fibroblast cell line; Aaronson et ai., 1968) have been described. They 
were maintained in RPMI-1640 medium containing 10%  FBS. 
Cerebellar cells were obtained from 8-d-old NMRI mice by dissociation 
with Dispase II (Boehringer Mannheim GmbH) as described (Faissner et 
al.,  1984).  The cells were maintained on poly-L-lysine-coated coverslips 
for 16 h or 3 d in basal medium Eagle's supplemented with 10% horse serum 
and 50 ~g/ml gentamycine (Sigma Chemical GmbH). N2A neumblastoma 
cells were maintained in cell culture bottles in Dulbecco's modified minimal 
essential medium (DMEM)  supplemented with  10%  FBS (Rathjen and 
Schachner, 1984), or they were maintained in the same culture medium on 
poly-L-lysine-coated glass coverslips for 3 d. 
Immunofluorescence Cytology 
To  localize  nectadrin  on  the  surface  of  cultured  cells,  indirect  im- 
munofluorescence cytology was performed as described by Schnitzer and 
Schachner (1981).  Coverslips carrying the cells were incubated for 1 h in 
50 #1 mAb 79-conditioned hybridoma culture medium. For control, uncon- 
ditioned medium and 100 ~ag/mi polyclonal rabbit antibodies to liver mem- 
branes were also used. The ceils were then washed in DPBS, fixed for 15 
rain  in  4%  paraformaidehyde  in  DPBS,  washed  again  in  Dulbecco's 
modified PBS (DPBS) (includes Ca  2+ and Mg2+), and incubated for 15 min 
in DPBS containing 1% BSA. They then were incubated for 20 min with 
FITC-conjugated  secondary  antibodies to  rat  immunoglobulins diluted 
1:100 in DPBS. All procedures were performed at room temperature. 
Cytofluorographic Analysis 
The expression of cell surface antigens was quantitated by indirect im- 
munofluorescence using a fluorescence activated cell sorter (FACScan with 
LYSYS II, Becton Dickinson Immunocytometry Systems, Mountain View, 
CA) as described (Lang et at.,  1987).  One million cells were harvested, 
washed twice in PBS, and incubated for 1 h with biotinytated mAb 79 to 
nectadrin at a concentration of 25 #g/ml, washed in PBS, and further incu- 
bated for 30 rain with phycoerythrin-conjugated  streptavidin (Sigma Chem- 
ical GmbH;  10 #g/ml).  FITC-conjugated mAbs to the B220 antigen and 
to Thy-1 (25/~g/mi) were then added to the cells after the cells had been 
thoroughly washed. The cells were washed again, resuspended in 500 #1 
PBS, and analyzed by cytofluorography. The mean relative fluorescence in- 
tensity per cell was evaluated from samples of 10,000 cells. All procedures 
were performed on ice. The content of nectadrin on antigen-coated latex 
beads was examined by the same procedure. 
Coating of  Latex Beads with Glycoproteins 
Latex beads were coated with nectadrin or with the soluble form of L1 or 
MAG (see above) as described (Kadmon et al., 1990a). To this end, DOW 7 
latex beads (Serva) with a 7-t~m mean diameter were used. For coating, 150 
~1 of a 10% bead suspension were mixed with a glycopmtein solution con- 
taining 20 t~g detergent-soluble nectadrin, 30 #g soluble L1, or 30/~g solu- 
ble MAG (55-100/~g/ml for each glycopmtein). LI and MAG were coated 
by an overnight incubation in an Eppendorf Mixer 5432  (Kurt Migge, 
Heidelberg, Germany) at 4~  Detergent-soluble nectadrin kept in Tris- 
HC1, pH 7.2, containing 0.2%  CHAPS (for h-nectadrin) or in Tris-HC1 
buffer,  pH  8.0, containing 0.1% deoxycholic acid (for 1-nectadrin)  was 
coated on a reciprocal shaker at 4~  during dialysis against PBS, pH 7.2, 
for 3 d with nine changes of the dialysis buffer according to Kadmon et al. 
(1990a).  For detergent-soluble antigens this coating procedure was chosen 
since the coating efficiency was highest when the detergent was removed 
from the antigen solution in the presence of the beads (not shown). 
The  coating  efficiency was  examined  by  Western blot  analysis  (not 
shown). For this purpose, the glycoprotein-coated beads were sedimented 
in the coating solution by centrifugation (5 min, 8,000 rpm in a Biofuge A 
centrifuge, Heraeus Sepatech, Osterode am Harz, Germany) and 30 ~1 of 
the supernatant were removed and mixed with 10 t~l of a 4 x  concentrated 
electrophoresis sample buffer (Laemmli,  1970).  The  sedimented beads 
were then resuspended and 30 #1 of  the suspension were removed and recen- 
trifuged.  The  pelleted  beads  were  thoroughly  washed  in  PBS  and 
resuspended in40 t~l electrophoresis  sample buffer. The presence of  the gly- 
coproteins in the supernatant and bead fractions was examined by Western 
blot analysis using polyclonal antibodies and applying the corresponding 
bead and supernatant fractions to adjacent lanes. After adding 7 ~g necta- 
drin, 10 ~g L1, or 10/~g MAG to the beads (approximately 8.5  x  105, 5.0 
x  103, and 7.5  x  103 molecules per bead for nectadrin, L1, and MAG, 
respectively), all of the glycoproteins were associated with the beads in that 
no remaining glycoproteins were detectable in the supernatant after coating. 
When 20 t~g nectadrin or 30 ~g L1 or 30/~g MAG were used ("~2.5  x  106, 
1.5 x  10  6, and 2.2 ￿  10  6 molecules per bead for nectadrin, L1, and MAG, 
respectively), the beads were saturated with respect to the coating protein 
and had no additional free protein binding sites in the sense that beads 
coated with nectadrin (nectadrin beads) or L1 (L1 beads) could not further 
bind MAG and MAG beads had no remaining free binding sites for necta- 
drin or L1. By cytofluorographic analysis the beads showed strong and uni- 
form expression of the coating antigens that was not reduced by preincubat- 
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Figure 2.  Determination of the expression of nectadrin by different cell lines and splenic 
B-lymphocytes. (A) Western blot analysis of the presence of nectadrin in different cell lines. 
Detergent-solubilized  lysates  of  the  cell  lines  BALB/3T3  (lane  1,  fibroblast  cell  line); 
P3x63Ag8.653  (lane  2,  plasmocytoma);  18.81  (lane  3,  pre-B-cell  line);  El-4  (lane  4, 
T-lymphoma); ESb 289 (lane 5,  T-lymphoma); WEHI 267.5  (lane 6, plasmocytoma); and 
Eb 288 (lane 7,  T-lymphoma) were separated by SDS-PAGE,  transferred to nitrocellulose 
sheets, and allowed to react with mAb 79 to nectadrin by Western blot analysis. The positions 
of molecular weight markers are indicated in kD at the fight margin. (B) Two-color cyto- 
fluorographic examination of the expression of nectadrin by B-lymphocytes in the spleen. 
Dissociated mouse spleen cells that include B- and T-lymphocytes were incubated with phy- 
coerythrin-conjugated  streptavidin only  (a)  or  with  biotinylated rat  mAb  to  nectadrin, 
visualized by phycoerythrin-conjugated streptavidin (b and c). The cells were then incubated 
with no further antibodies (a) or with FITC-conjugated rat mAb to the B-lymphocyte marker 
antigen B220 (b) or FITC-conjugated rat mAb to the T-lymphocyte marker antigen Thy-1 
(c).  Ordinate and abscissa denote the relative fluorescence intensity per cell measured for 
phycoerythrin and FITC, respectively. Results are from one representative experiment using 
10,000 cells per sample. 
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ing the beads with 1 mg/ml BSA. The mean fluorescence intensity per bead 
was compared with the mean fluorescence intensity  per activated B-lympho- 
blast tested in parallel  using the same antibodies and measured under the 
same adjustment of parameters in the fluoroscanner. 
Homotypic Aggregation of CeUs and 
Glycoprotein-coated Latex Beads 
The aggregation of cells and of glycoprotein-coated  latex beads was tested 
as described (Kadmon  et al.,  1990a).  LPS-activated  B-lymphocytes  were 
suspended  in PBS,  pH  7.2,  containing 2  mg/ml EDTA and beads were 
resuspended  mechanically by using a Vortex mixer.  Both cells and beads 
were further washed in PBS, pH 7.2, before the aggregation  test. For the 
analysis of the aggregation,  25 #1 of a cell suspension containing "~100,000 
cells or 10/~l of a bead suspension containing "~300,000 beads were added 
to Ca  2+ and Mg2+-free HBSS  or DPBS  in 24-well  tissue culture plates 
(Costar Corp., Cambridge, MA) to a final volume of 300/zl per well. For 
cells,  the wells had been precoated with PBS containing 100 mg/ml heat- 
treated (75 ~  20 min) BSA to prevent the adhesion of the cells to the plastic 
surface. When antibodies or antigens were added to the cells or beads, they 
first were incubated with the cells or beads for 30 rain on ice to allow for 
good binding. For cells, antibodies and antigens were added to a final con- 
centration of 100 and 20/~g/ml, respectively. For beads, the concentrations 
of antibodies and antigens  were 35-70/~g/ml and 10/~g/ml, respectively. 
For all experiments,  it was ascertained by titration that at these concentra- 
tions the antibodies and antigens produced  their maximal inhibitory effect 
(not shown), mAb M1/69 and the polyclonal antibody to nectadrin were ad- 
ditionally  tested in the cell aggregation assay at concentrations of up to 10 
mg/ml. 
For cell and bead aggregation,  the culture plates were incubated at 37~ 
and at room temperature, respectively, at a rotation speed of 85 rpm for the 
durations specified in the figure legends.  Aggregation  was stopped by plac- 
ing the culture plates on ice and by dilution of'the ceils and beads in the 
Coulter Counter electrolyte  solution. The degree of aggregation was evalu- 
ated microscopically  and by Coulter Counter analysis  (see  below).  All 
aggregation  experiments  were performed in triplicates or in hexaplicates. 
Heterotypic Aggregation of Glycoprotein-coated 
Latex Beads 
In addition to the homotypic aggregation of latex beads coated with one gly- 
coprotein or with a mixture of two glycoproteins,  the heterotypic aggrega- 
tion of beads coated  with different glycoproteins  was also examined.  For 
the analysis  of heterotypic  aggregation,  the differently coated beads were 
added either to the same well, where they could coaggregate, or to two sepa- 
rate wells,  in which case they were mixed together for measurement only 
after their aggregation  had been terminated.  The difference  in particle 
aggregation seen with the two procedures as evaluated by Coulter Counter 
analysis was taken to represent the heterotypic  aggregation (coaggregation) 
of the differently coated beads (see Fig. 8; see also Kadmon et al.,  1990a). 
All aggregation  experiments  were performed in triplicates  or in hexapli- 
cates. 
Coulter Counter Analysis of  Aggregation 
The aggregation  of cells and beads was quantitated in a Coulter Counter 
model TAll  fitted with a Population Accessory using a nozzle 200/zm in di- 
ameter (Coulter Corp., Hialeah,  FL). For the analysis of aggregation,  the 
distribution  of partial volume (vol %) over the different channel numbers was 
used.  The channel numbers correspond to particle size, that is, to the size 
of single cells or beads and to the sizes of their aggregates.  The vol% value 
read for each channel number corresponds to the percent of all cells or 
beads that are present in particles of the size measured in the respective 
channel number.  The inhibition of aggregation  was  evaluated  from the 
reduction in the cumulative vol% value corresponding to large aggregates 
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compared to the aggregation  in the absence of additives. 
For the evaluation  of the beterotypic  aggregation of differently  coated 
beads, the vol% distribution curves  obtained  when the differently  coated 
beads had been mixed together  prior to and after aggregation  were com- 
pared (see Fig. 8 B). Additionally, the total number  of particles per well 
(N) before and after aggregation was also evaluated (Fig. 8 C). Before 
aggregation, N is equal to the number of single beads added to each well 
and is equal for all wells. The number of particles, N, then decreases in 
proportion to the degree  of aggregation (Fischer and Schachner, 1982). 
Statistical Analysis 
For statistical  evaluation  of  the restdts, one way nested  analysis  of  variance 
(nested anova)  and multiple  comparisons among  means using the GT2 and 
Smdent-Neuman-Keuls methods with c~ ~ 0.01 were performed. All the 
statements in this work concerning  differences  between  the quantitative  ef- 
fects of different  treatments are based on one of these multiple comparison 
tests but reference  to the actual test has been omitted. 
Results 
Characterization of  a Novel mAb to the HSA 
Designated Nectadrin 
mAb 79 resulted from the immunization of a rat with plasma 
membranes from the lymphoma cell line ESb 289 (Altevogt 
et al.,  1989b; see also Fig. 2 A). The antibody reacted by 
indirect immunofluorescence and Western blot analysis also 
with other established mouse tumor lines of haematopoietic 
(P3x63Ag8.653,  18-81, and WEHI 26Z5; Fig. 2 A) origins 
as well as with normal lymphoid and neural cells (see Fig. 
4).  The apparent molecular weights  of the antigen recog- 
nized by mAb 79 varied between 30 and 68 kD, depending 
on the cell type (Fig. 2 A). The broad size distribution was 
also noted when lysates from normal thymocytes, B-lympho- 
cytes, and erythrocytes were examined (not shown). In ESb 
289 cells, two immunoreactive bands were seen of 23 and 
40-60 kD (Fig.  2 A,  lane 5).  The binding of mAb 79 to 
thymocytes could  partially  be  blocked  by  mAbs  M1/69, 
B2A2, and J1 ld to the HSA but not by antibodies to CD2 (not 
shown). It has recently been shown that mAb 79 as well as 
the polyclonal nectadrin antibody recognize the bacterial fu- 
sion protein of the heat-stable antigen (Wenger et al., 1991). 
Characterization of  High and Low Molecular Weight 
Forms of Nectadrin 
To study the functional properties of the isolated molecule, 
nectadrin was purified from plasma membranes of ESb 289 
lymphoma cells. Two forms of nectadrin were isolated from 
these cells, one of 40-60 kD, designated h-nectadrin (Fig. 
3 A, lanes 1-5), and one of 23-30 kD, designated 1-nectadrin 
(Fig.  3 A,  lanes 6-10). h-nectadrin was isolated biochem- 
ically as outlined in Fig. I. Immunoatfinity purification using 
monoclonal antibody 79 predominantly yielded 1-nectadrin 
and, to a minor extent that varied from batch to batch, also 
h-nectadrin.  L-nectadrin  appeared  in  higher  amounts  in 
membranes following several cycles of  thawing and freezing. 
Both forms of nectadrin were recognized in Western blot 
analysis by mAb 79 to nectadrin (Fig. 3 A, lanes 5 and 7) 
and by/nAbs Jlld (Fig. 3 A, lanes 2 and 9), M1/69  (Fig. 3 
A, lanes 3 and 8), and B2A2 (Fig.  3 A, lanes 4 and 10) to 
the HSA, but not by mAb 12.15 to CD2 (Fig. 3 A, lanes 1 
and  6)  or by polyclonal antibodies  to L1  (Fig.  3 B,  lane 
/) or N-CAM (Fig. 3 B, lane 2).  The polyclonal antibody 
to nectadrin primarily reacted with h-nectadrin (Fig. 3 B, 
lane 3). 
To further characterize the differences between the two 
forms of nectadrin, the glycan structures of the two forms 
were compared by means of lectin binding.  Datum stra- 
monium agglutinin, recognizing Gal/3(1-*4)GlcNAc, strongly 
reacted with h-nectadrin (Fig. 3 D, lane 3). Maackia amu- 
rensis agglutinin,  recognizing mainly  NANAc~(2~3)Gal, 
reacted clearly although less well with h-nectadrin (Fig. 3 
D, lane 2). Both agglutinins reacted weakly with l-nectadrin. 
Concanavalin A (Fig. 3 D, lane 4), Galanthus nivalis agglu- 
tinin (Fig. 3 D, lane 5), recognizing terminal Man-Man, and 
Sambucus nigra agglutinin (Fig. 3 D, lane 6), recognizing 
NANAc~(2-'*6)Gal,  predominantly reacted with 1-nectadrin. 
Aleuria  arantia  agglutinin  recognizing  L-Fucu(1--*6)core 
N-acetylglucosamine (Fig.  3 D, lane  7) and Ulex europeus 
agglutinin recognizing terminally linked fucosec~(1---2) (not 
shown) did not react with any of the nectadrin forms. Thus, 
the carbohydrate composition of the two forms, h-nectadrin 
and 1-nectadrin, is better recognized by Iectins that bind to 
terminal sugars of complex type N-linked glycans and core 
oligosaccharides of N-linked complex or high-mannose type 
glycans, respectively. The observation that the two forms of 
nectadrin comigrate in Western blots after N-deglycosyla- 
tion (Fig. 3 E) also supports the notion that they primarily 
differ in the composition or number of their N-linked gly- 
cans, although small differences in the apparent molecular 
weights of the N-deglycosylated proteins would not be de- 
tected by this analysis. 
L-nectadrin is reminiscent of the 23-kD form of the HSA 
described by Kay et al. (1990) in HSA-transfected COS cells 
as  a  putative precursor  of the  mature,  higher molecular 
weight glycoprotein. To investigate the possible precursor- 
mature protein relationship between 1-nectadrin and h-nec- 
tadrin, we examined the biosynthesis of nectadrin. Necta- 
drin  was  immunoprecipitated  from  detergent-solubilized 
ESb 289 cells after biosynthetically labeling the cells for 
24 h with a mixture of radioactive fucose, glucosamine, and 
galactose. This labeling procedure was used since nectadrin 
contains  neither cysteine nor methionine (Wenger et al., 
1991)  and labeling  with  radioactive amino acid  mixtures 
yields only weak incorporation of radioactivity into the pro- 
teins. After this treatment, h-nectadrin was easily observed 
whereas 1-nectadrin could not be detected (Fig. 3 C). l-nec- 
tadrin thus appears to represent a form of the antigen with 
a truncated carbohydrate content that is probably generated 
during the storage and purification process rather than being 
a precursor form of h-nectadrin. 
Immunocytological Localization of  Nectadrin at 
CeU-CeU Contact Sites 
Our interest in nectadrin was instigated by the observation 
that different cell types that interact to form cell-cell con- 
tacts in tissue culture preferentially express the antigen at 
their contact sites (Fig. 4). This accumulation of nectadrin 
at cell-cell contact sites was seen by indirect immunofluores- 
cence cytology using both monoclonal (Fig.  4) and poly- 
clonal (not shown) antibodies to nectadrin.  We examined 
activated splenic B-lymphocytes (Fig. 4, a  and b), neuro- 
blastoma N2A cells (Fig. 4, c and d), and cerebellar cells 
(Fig. 4, e-h) in culture. In cerebellar cells, 16 h after plating, 
nectadrin was only found on cells with a neuronal morphol- 
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h-  and  1-nectadrin  by  SDS- 
PAGE and Western blot anal- 
ysis.  (A)  The  biochemically 
purified high molecular  weight 
form of  nectadrin, h-nectadrin 
(lanes 1-5), and immunoatfin- 
ity-purified nect adrin, primar- 
ily containing the low molecu- 
lar weight form, 1-nectadrin, 
but  also  h-nectadrin  (lanes 
6-10)  were separated  by 8% 
SDS-PAGE and examined by 
Western  blot  analysis  using 
mAbs to CD2  (12.15, lanes 1 
and 6), the HSA (Jlld, lanes 2 
and 9; M1/69, lanes 3 and 8; 
B2A2,  lanes  4  and  10),  and 
nectadrin (79, lanes 5 and 7). 
(B) The two forms of necta- 
drin  shown in lanes  1-5 and 
6-9 in A were mixed together 
at a 1:1 weight ratio, separated 
by 8%  SDS-PAGE and  ana- 
lyzed by Western blot analysis 
using polyclonal antibodies to 
LI (lane 1 ), N-CAM (lane 2), 
or nectadrin (lane 3). (C) ESb 
289  cells  were  labeled  for 
24 h with 3H-labeled fucose, 
glucosamine,  and  galactose. 
They then  were lysed  in the 
presence of detergent.  Necta- 
drin  was immunoprecipitated 
using a mixture of mAbs (lane 
1 ) or the secondary antibody 
to rat immunoglobulins alone 
(lane 2), separated by 8% SDS-PAGE, and examined by autoradiography.  (D) h- and l-nectadrin were mixed together, separated by 10% 
SDS-PAGE, and examined by Western blot analysis using mAb 79 (lane 1) or lectin binding analysis using digoxigenin-labeled agglutinlns 
from Maackia araurensis (lane 2), Datum stramonium (lane 3), Galanthus nivalis (lane 5), Sambucus nigra Oane 6), and Aleuria aurantia 
(lane 7) as well as concanavalin A (lane 4). (E) h- and 1-nectadrin were mixed together, incubated overnight in the absence (lane I ) or 
presence (lane 2) of endoglycosidase F/N-glycopeptidase  E  separated by 15% SDS-PAGE, and examined by Western blot analysis using 
monoclonal nectadrin  antibody 79. After endoglycosidase F/N-glycopeptidase  F digestion,  only one immunoreactive  nectadrin  band is 
seen (arrowhead).  Notice that the enzyme endoglycosidase F/N-glycopeptidase F is also seen (arrow). The positions of molecular weight 
markers are indicated in kD at the left margins of the blots in A, B, and E. The positions of h- and l-nectadrin  in C and D are marked 
on the left margin of C. 
ogy. It was predominantly expressed at contact sites between 
cell bodies, between neurites and cell bodies, and between 
neurites.  After 3  d  in culture,  the expression of nectadrin 
also was mainly confined to contact sites between neuronal 
cell bodies and to fasciculating neurites (Figs. 4, g  and h). 
For comparison, antibodies recognizing all forms of N-CAM 
evenly bind all over the surface of N2A cells and cerebellar 
neurones after 1 d in culture, but preferentially label cell-cell 
contact sites after longer periods of culture, when the cells 
primarily express N-CAMps0,  the largest form of N-CAM 
that is specifically localized at cell-cell contact sites (Poller- 
berg et al.,  1985). After 3 d in culture under the conditions 
used in the present work these cells preferentially express 
N-CAM at their contact sites, but also elsewhere on the cell 
surface.  Polyclonal antibodies  to  mouse  liver membranes 
and to ESb  289 cell membranes have also been used and 
uniformly labeled the surface of the neural and spleen cells, 
respectively (not shown). The apparent localization of nec- 
tadrin  to  cell-cell  contact  sites  prompted us  to  examine 
whether  nectadrin  may  be  involved  in  mediating  cell 
adhesion. 
Nectadrin-dependent Aggregation of B-Lymphocytes 
To evaluate whether nectadrin may mediate cell-cell adhe- 
sion, cell aggregation tests were performed. The aggregation 
of LPS-activated B-lymphocytes that express nectadrin was 
examined in the presence and absence of antibodies to nec- 
tadrin or the purified antigen itself (Fig. 5). In the presence 
of physiological levels of Ca  :+ and  Mg  ~+,  the  cells aggre- 
gated well as evaluated b Coulter Counter analysis after 2 h 
of incubation in suspension at 37~  with the modal particle 
size measured in the  Coulter Counter reaching channel  9 
(Fig.  5  A).  When  monoclonal nectadrin  antibody 79  was 
added in the presence of Ca  2+ and Mg  2+, the aggregation of 
B-lymphocytes was  reduced  by  ~70%  as  compared with 
Kadmon et aL Nectadrin Is a Cell Adhesion Molecule  1251 Figure 4. Indirect immunocytological localization of nectadrin at cell--cell  contact sites in lymphoid and neural cells in culture. Primary 
cultures of splenocytes (a and b), N2A neuroblastoma cells (c and d), and primary cultures of early postnatal cerebellar cells (e-h) were 
grown on poly-L-lysine-coated  coverslips for 2 (a and b) or 3 (c, d, g, and h) d, or for 16 h (e and f). Nectadrin was then visualized 
by indirect immunofluorescence staining using mAb 79 to nectadrin (a, c, e, and g); b, d, f, and h are the corresponding phase-contrast 
micrographs to fluorescence images a, c, e, and g, respectively. Nectadrin is concentrated at contact sites between cell bodies (large arrow- 
heads in a-f), between neurites and cell bodies (small arrows in e and f), between neurites that meet head-on (small arrowheads in e 
and f), and between fasciculating neurites (/arge arrows in g and h). 
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Figure 5.  Determination of the aggregation of nectadrin-positive 
B-lymphocytes. LPS-activated B-lymphocytes were allowed to ag- 
gregate for 2 h in the absence or presence of antibodies (A and B) 
or purified antigens (C). The aggregation was quantitatively deter- 
mined by Coulter Counter analysis. (A) Particle size distribution of 
the cells, indicated by vol%, before aggregation (dotted line) and 
after they were allowed to aggregate in the absence (broken line) 
or presence (solid line) of mAb 79 to nectadrin. Channel numbers 
4-6, 7-9, and 10-13 correspond to single cells and small and large 
aggregates of cells, respectively. Values are means from one repre- 
sentative experiment performed in hexaplicate. (B) Effects of  mAbs 
to nectadrin (79, M1/69, Jlld), LFA-1 (18.5), and CD2 (12.15), and 
of  polyclonal IgG antibodies from nonimmunized rats (rlgG) on the 
aggregation of B-lymphocytes. Values are means from at least four 
independent experiments, each performed in triplicate or hexapli- 
cate. (C) Inhibition of  aggregation of  B-lymphocytes by the purified 
antigens nectadrin (Nec; a mixture of h- and l-nectadrin), CD2, or 
N-CAM (NCAM). The deoxycholic acid-containing buffer (DOC), 
in which nectadrin and N-CAM had been prepared, was used as 
control.  Values are means from three independent experiments, 
each performed in hexaplicate. 
their aggregation in the absence of the antibody (Fig. 5, A 
and B). A similar inhibitory effect was observed when puri- 
fied nectadrin was added to the cells instead of the antibody 
(Fig. 5  C). 
mAb FD18.5 to LFA-1 was also tested and found to inhibit 
the aggregation by ,o60-70% (Figs. 5 B and 6 A). mAb Jlld 
(Fig.  5 B) that also recognizes nectadrin as well as mAb 
12.15 to CD2 (Fig. 5 B) that binds to B-lymphocytes (Alte- 
vogt et al., 1989b), nonspecific rat IgG molecules (Fig. 5 B) 
that include the same isotypes as the monoclonal nectadrin 
antibodies used and that may bind to Fc receptors, and poly- 
clonal antibodies to N-CAM (Fig. 6 A) that may bind to Fc 
receptors recognizing rabbit IgG molecules, did not signifi- 
cantly affect the aggregation of B-lymphocytes. Recombi- 
nant CD2 fusion protein and purified soluble N-CAM also 
did not significantly inhibit the aggregation of these cells 
(Fig. 5 C). In contrast to these results, mAb M1/69 that rec- 
ognizes nectadrin (Fig. 5 B) and the polyclonal antibody to 
nectadrin (not shown) enhanced the aggregation of the cells. 
This enhancement of aggregation was observed even at anti- 
body concentrations of up to 10 mg/ml (not shown). 
Since antibodies to LFA-1 (Fig. 5 B) and L1 (Kowitz et al., 
1992)  have been shown to inhibit the aggregation of LPS- 
activated B-lymphoblasts the question arose, whether LFA-1, 
L1, and nectadrin have an additive effect in mediating B-lym- 
phoblast aggregation or may display interdependent behav- 
ior. When polyclonal antibodies to L1 were added to the ceils 
in mixture with monoclonal nectadrin antibody 79 or with 
monoclonal LFA-1 antibody FD18.5, the aggregation-inhibit- 
ing effects of the combined antibodies were additive (Fig. 6 
B),  suggesting that L1 mediates the aggregation of B-lym- 
phoblasts by a mechanism that is independent of nectadrin 
and LFA-1. On the other hand, when nectadrin antibody 79 
and LFA-1 antibody FD18.5, each of which inhibited B-lym- 
phoblast aggregation by "o60%  (Fig.  6 A) were mixed to- 
gether cell aggregation also was inhibited by "o60% (Fig. 6 
B). The combined aggregation-inhibiting effect of  these anti- 
bodies to nectadrin and LFA-1 therefore is not additive, sug- 
gesting that the adhesion mechanisms mediated by nectadrin 
and LFA-1 may be related to one another. 
The cells also aggregated in the absence of the divalent 
cations although much less extensively than in their presence 
(not shown),  with the model particle size measured in the 
Coulter Counter reaching only channel 7  (for the channel 
distribution of the cells before and after aggregation in the 
presence of divalent cations, see Fig. 5 A). However, after 
1 h of incubation in the absence of Ca  2§ and Mg  2+ substan- 
tial cell death was noted. In the absence of Ca  ~§ and Mg  ~+, 
monoclonal nectadrin antibody 79 inhibited the weak aggre- 
gation of the ceils by "o60% and almost complete inhibition 
was achieved by the combination of mAb 79 and polyclonal 
L1 antibodies (not shown). Under these conditions, the ag- 
gregation of LPS-activated B-lymphoblasts was not affected 
by monoclonal LFA-1 antibody FD18.5 (not shown).  How- 
ever, in the absence of the divalent cations many cells ap- 
peared unhealthy and a detailed analysis of their aggregation 
therefore was not performed. 
Aggregation of Nectadrin-coated Latex Beads 
Latex beads were coated either with biochemicaUy purified 
h-nectadrin (h-nectadrin beads) or with immunoaffinity puri- 
fied l-nectadrin containing a minor amount of h-nectadrin (1- 
nectadrin beads) and their ability to aggregate was then ex- 
amined. By cytofluorescence analysis using constant appa- 
ratus settings, h-nectadrin and 1-nectadrin beads carried sim- 
ilar amounts of nectadrin (relative fluorescence per bead = 
154  and 97,  respectively; background fluorescence values 
have been subtracted) to the level of nectadrin on LPS-acti- 
rated B-lymphoblasts (mean relative fluorescence per cell = 
151). The mean diameters of the cells and beads were 12 and 
7/~m, respectively, suggesting that nectadrin was two to three 
times more concentrated on the surface of the beads than on 
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Figure 6. Determination of the aggregation of B-lymphocytes in the presence of antibodies to nectadrin, L1, N-CAM, and LFA-1. LPS- 
activated B-lymphocytes were allowed to aggregate for 2 h in the presence or absence of monoclonal nectadrin antibody 79, monoclonal 
LFA-1 antibody FDI8.5 (18.5), or polyclonal antibodies to LI (pL/) or N-CAM (pN-CAM). Aggregation was quantitated by Coulter Counter 
analysis and the reduction in aggregation in the presence of antibodies as compared with the aggregation in their absence (% inhibition) 
was evaluated. The antibodies were added either separately (A; [] in B) or in different combinations (m in B) as indicated under the bars 
in B. The inhibition observed in the presence of antibody combinations (r~ in B) was compared to the calculated sum of the mean inhibition 
values obtained when the corresponding antibodies were separately added to the cells ([] in B; values taken from A). Values are means 
from three independent experiments, each performed in triplicate. 
the cells.  However, in the  absence of information on the 
membrane  distribution  of nectadrin  in  single  suspended 
ceils, the effective concentration of nectadrin on the cell sur- 
face could not be determined. 
H-nectadrin beads could aggregate well.  Their aggrega- 
tion was observed already within 10 min (not shown). It was 
documented microscopically after 1 h (Fig. 7 A,a) and quan- 
titated by Coulter Counter analysis after 3 h (Figs. 7, B and 
C, and 8 A) of aggregation. L-nectadrin beads formed only 
loose, but characteristic aggregates (Fig. 7 A,b) that could 
not be measured by Coulter Counter analysis (Figs. 7 B and 
8 A), since they disintegrated upon passing through the noz- 
zle of the apparatus due to the shearing forces. In this analy- 
sis  l-nectadrin beads  therefore show  only few,  small  ag- 
gregates.  Latex beads coated with L1  and with the MAG 
were used as positive and negative controls, respectively. L1 
beads  aggregated strongly (Fig.  7, A,c and B)  and MAG 
beads did not aggregate (Fig. 7, Ad and B; see also Kadmon 
et al.,  1990a). 
The aggregation of h-nectadrin beads was completely in- 
hibited in the presence of polyclonal antibodies to nectadrin 
or purified h-nectadrin as evaluated by Coulter Counter anal- 
ysis after 3 h of incubation (Fig. 7 C). Their aggregation was 
inhibited by  '~75%  when purified 1-nectadrin  was  added 
(Fig. 7 C), but it was perturbed neither by purified N-CAM 
nor by purified MAG (Fig. 7 C). 
The observation that the aggregation of h-nectadrin beads 
can be inhibited by l-nectadrin suggested that the two forms 
of nectadrin may interact with one another. This possibility 
was tested by examining whether 1-nectadrin beads, which 
do not aggregate on their own in a manner that is detectable 
by Coulter Counter analysis (Figs. 7 B and 8 A), can coag- 
gregate together with h-nectadrin beads (Fig. 8, B and C). 
When l-nectadrin beads and h-nectadrin beads were mixed 
and allowed to aggregate together, a significant decrease in 
the partial volume occupied by single beads as well as an in- 
crease in the partial volume occupied by small and medium- 
size  aggregates  were  measured,  as  compared  with  the 
respective values when the beads had been mixed together 
only  after  their  separate  aggregation  (Fig.  8  B).  These 
results show that beads coated with the two forms of necta- 
drin can coaggregate, but that the resulting coaggregates are 
smaller  than  those produced by  h-nectadrin  beads  alone 
(Fig. 8, A and B). 
Discussion 
In the present study we show that both purified nectadrin and 
the mAb to nectadrin inhibited the homotypic aggregation 
of B-lymphocytes by •70  %, suggesting that nectadrin may 
act as a ligand mediating adhesion among nectadrin-positive 
cells. 
Nectadrin was isolated and characterized by means of the 
novel mAb 79 and several lines of evidence suggested that 
it is identical to the HSA (Springer et al.,  1978). These in- 
cluded the serological identity of nectadrin and the HSA as 
well as their identical electrophoretic migration and develop- 
mentally regulated tissue distribution (M.  Eckert, unpub- 
lished observations). Nr  and the HSA are sensitive to 
phospholipase C treatment in the same cell types and anti- 
bodies to the HSA partially inhibit the binding of mAb 79 
to live cells (M. Eckert, unpublished observations). Further- 
more, mAbs M1/69, B2A2, Jlld, and 79 and the polyclonal 
nectadrin antibody all recognize the bacterial fusion protein 
encoded by the cDNA of  the HSA (Wenger et al., 1991). This 
indicates that all these antibodies react with the 30-amino 
The Journal of Cell Biology,  Volume 118, 1992  1254 Figure 7. Determination of the aggregation of latex beads coated with nectadrin. Latex beads coated with the biochemically purified, high 
(h-nectadrin)  or immunoaffinity purified, low (l-nectadrin) molecular weight forms of nectadrin were allowed to aggregate for 1 (A) or 
3 (B and C) h.  (A) The aggregation of h- (a) and 1-nectadrin (b) beads was examined by phase-contrast microscopy. For controls, beads 
coated with LI (c) that aggregate and beads coated with the myelin associated glycoprotein (d) that do not aggregate (Kadmon et al., 1990a) 
were also tested. (B) Aggregation of beads coated with h-nectadrin (h-Nec), l-nectadrin (l-Nee), I2, or MAG as measured by the Coulter 
Counter distribution of particle size before (to) or after aggregation. Open, shaded, and closed bars correspond to the partial volumes 
(l,  bl %) occupied by single beads (channel numbers 46) and small (channel numbers 7, 8) and large (channel numbers 1>9) aggregates, 
respectively. (C) Beads coated with h-nectadrin were allowed to aggregate for 3 h in the absence or presence of purified h-nectadrin (h-Nec), 
1-nectadrin (l-Nec), MAG, or N-CAM (NC), or polyclonal antibodies to nectadrin (pNec). Aggregation was quantitatively determined by 
Coulter Counter analysis. The reduction in the formation of large aggregates of h-nectadrin beads in the presence of these additives as 
compared to the formation of large aggregates in the absence of additives is indicated as percent inhibition. Values  in B and C are means 
from at least three independent experiments, each performed in triplicate or hexaplicate. 
acid polypeptide core of the glycoprotein (Kay et al.,  1990; 
Wenger et al.,  1991). 
Although  nectadrin  has  different  apparent  molecular 
masses in different tissues and cell lines, only one nectadrin 
gene, designated gene A, is expressed in all the tissues that 
have  been  examined,  brain,  thymus,  bone  marrow,  and 
spleen as well as in pre-B and erythroid cell lines  (Rougon 
et al.,  1991;  Wenger et al.,  1991),  and in the  T-lymphoma 
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Figure 8. Determination  of  the coaggregation  of  l-nectadrin-coated 
beads with h-nectadrin-coated  beads. Latex beads coated with 
l-nectadrin or h-nectadrin were allowed to aggregate for 3 h either 
separately or mixed together. Aggregation  was quantitated by Coul- 
ter Counter analysis. (A) Distribution of  particle size ofl-nectadrin 
(---o---) and h-nectadrin (-o-) beads after separate aggregation. 
Single beads, small and large aggregates are measured in channel 
numbers ~6, 7-8, and ;*9, respectively.  Whereas 1-nectadrin  beads 
only form few, small aggregates  by this method, h-nectadrin beads 
aggregate  to form large aggregates. Values  are from one representa- 
tive experiment performed in hexaplicate. (B) L-nectadrin and 
h-nectadrin beds were mixed together either before (-i-) or after 
(. ￿9 .A- ￿9 .) aggregation. Coaggregation of the differently coated 
beads is indicated by a reduction in the partial volume occupied by 
single beads (channel numbers 4-6) and an increase in the partial 
volume occupied by aggregates (channel numbers 7-14). L-necta- 
drin beads that do not aggregate on their own, when measured by 
Coulter  Counter  analysis, aggregate together with h-nectadrin 
beads to form small and medium sized aggregates. Values are 
means from  one  representative experiment performed in  hex- 
aplicate. 
cell line ESb 289  (P.  Nielsen, personal communication). 
There has been no evidence for alternative splicing of this 
nectadrin gene A (Kay et ai.,  1990;  Wenger et al.,  1991). 
The mature polypeptide coded by gene A is expected to have 
only 30 amino acids with a molecular mass of 2.7 kD (Kay 
et al., 1990;  Wenger et al., 1991) and the differences of up 
to 40 kD in the apparent molecular mass of nectadrin in 
different cell types appear to result mainly, if not only from 
variations in its N-Linked and O-Linked glycosylation (Alter- 
man et al., 1990; Kay et al., 1990; Rougon et al., 1991) that 
accounts for 85-95 % of its apparent molecular mass. 
In the present study, two forms of nectadrin of 23-30 and 
40-60 kD that were both recognized by Western blot analysis 
by the different nectadrin antibodies were differentially iso- 
lated from ESb 289 cells. Since ESb 289 cells only express 
the phosphatidylinositol-anchored  gane A product of necta- 
drin these different forms probably differ from one another 
in their posttranslational modifications, presumably in the 
content and/or structure of their glycans. This notion is sup- 
ported by the similar migration of h-nectadrin and l-necta- 
drin in SDS-PAGE  after N-deglycosylation and by differ- 
ences in the binding of  lectins to the two forms of  the antigen. 
L-nectadrin appeared in ESb 289 cell membrane prepara- 
tions in increasing amounts, relative to h-nectadrin, after 
long storage and handling of the membranes, indicating that 
it had been generated from h-nectadrin during this process. 
Biosynthetic labeling  experiments  subsequently  failed  to 
demonstrate the presence  of l-nectadrin in live ESb  289 
cells. The low molecular mass form of nectadrin therefore 
appears to be a degraded form of h-nectadrin that primarily 
differs from h-nectadrin in its carbohydrate content. 
These two forms of nectadrin not only differ in their struc- 
ture, but also in their function in self-recognition. As evalu- 
ated from the aggregation of latex beads coated with the 
different forms of nectadrin, the adhesive properties of the 
two forms were strikingly different in that the 40-60-kD 
form appeared to be much more adhesive than the 23-30-kD 
form. Interestingly, the two forms can interact with one an- 
other, indicating that the binding between nectadrin mole- 
cules may possibly involve different domains that are in part 
common to both forms of the molecule. These observations 
suggest that nectadrin may mediate cell adhesion by a necta- 
drin-nectadrin  interaction that depends  on  its  structure, 
most likely on its oLigosaccharide composition. Moreover, in 
view of  the unusually high carbohydrate content in the necta- 
drin molecule, the glycan structures of nectadrin are likely 
to have direct functional importance and it is tempting to 
speculate that the binding between nectadrin molecules may 
even result from glycan-glycan interactions. A specific gly- 
can-glycan interaction that mediates cell adhesion has previ- 
ously been reported for the Lewis ￿  (Le,) determinant. Le  , 
glycans have been shown to mediate the adhesion between 
F9  embryonai carcinoma cells by homophilic interaction 
(Eggens et al., 1989) and have been suggested to have a role 
in the compaction of the murine embryo at the morula stage 
(Fenderson et ai.,  1984). 
The conjecture that different domains of the  nectadrin 
molecule may have diverse functional roles was pointed at 
by the variable effects that monoclonal and polyclonal necta- 
drin antibodies had on B-cell aggregation. In contrast to the 
inhibition of cell aggregation by mAb 79, other nectadrin- 
specific mAbs, J11d and B2A2, did not interfere with the 
aggregation whereas monoclonal nectadrin antibody M1/69 
and the polyclonal nectadrin antibody enhanced the aggrega- 
tion of the cells. This increase in aggregation occurred also 
when the antibodies were used at very high concentrations, 
thus rendering the possibility of cross-linking between the 
cells unlikely. The possibility of  cross-Linking also seems un- 
likely in view of the observation that polyclonal nectadrin 
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hibited the aggregation of nectadrin-coated latex beads when 
used at similar concentrations.  No increase in aggregation 
was seen when polyclonal rabbit IgG antibodies to N-CAM 
or nonspecific rat IgG molecules that included the same iso- 
type as mAb M1/69 were used, ruling out that the enhanced 
aggregation  would have  resulted  from antibody-dependent 
Fc receptor-mediated stimulation of aggregation. It therefore 
is conceivable that antibody M1/69 and the polyclonal anti- 
body to nectadrin may either directly enhance the capacity 
of nectadrin to mediate cell binding by altering  the confor- 
mation of the molecule, or indirectly trigger other adhesion 
molecules via intracellular second messengers by binding to 
nectadrin. 
In this context, it is interesting that the mixture of necta- 
drin antibody 79 and LFA-1 antibody FD18.5  inhibited the 
aggregation of B-lymphoblasts  to the same extent as when 
each of these antibodies had been used on its own. This ob- 
servation  could  indicate  that  the  LFA-1 and  nectadrin- 
dependent  adhesion  mechanisms  which  are  perturbed  by 
these antibodies may be related to one another. Since necta- 
drin appears  to mediate the aggregation of cells and beads 
also in the absence of divalent cations, that is, under condi- 
tions that render LFA-1 inactive, it does not seem likely that 
the  two molecules  mediate  cell  adhesion  as  a  ligand  and 
receptor  pair.  However,  in  view  of results  showing  that 
nectadrin (Kadmon,  G., M.  Eckert, P. Horstcorte, and M. 
Schachner, manuscript submitted for publication) and its hu- 
man homologue, CD24 (Fischer et al.,  1990),  are involved 
in mediating signal transduction, it is possible that LFA-1 and 
nectadrin are functionally  related  via a  second messenger 
pathway. Similar cellular consequences of antibody binding 
to cell-surface antigens have previously been reported to ac- 
tivate  LFA-l-dependent  T-cell  adhesion:  LFA-l-dependent 
homotypic  T-cell  adhesion  is  transiently  enhanced  after 
binding of CD3 antibodies and persistently enhanced after 
binding of CD2  antibodies  to the cells (van  Kooyk et al., 
1989).  The stimulation of LFA-1 after the binding of anti- 
bodies to CD3 and CD2 appears to be regulated by a protein 
kinase C-dependent mechanism (van Kooyk et al., 1989). In 
T-cells LFA-1 is also activated  via protein kinase C by some 
CD44 antibodies (Koopman et al.,  1990),  whereas another 
CD44 antibody has been reported to inhibit the CD2/LFA- 
3-mediated adhesion between T-cells and erythrocytes, pos- 
sibly via a cis interaction between CIM4 and CD2 on the cell 
membrane (Hale et al.,  1989). 
Nectadrin is expressed in polymorphic forms by as differ- 
ent cells as neurones, lymphocytes, monocytes, and erythro- 
cytes and it is conceivable that it may mediate cell adhesion 
by a variety of mechanisms. In addition to its putative ability 
to mediate cell adhesion by a nectadrin-nectadrin  interac- 
tion, it is possible that it may also bind to glycan-binding ad- 
hesion molecules.  Several lectins and glycosyl transferases 
that bind to carbohydrates  of different specificities have been 
suggested to mediate neuronal adhesion in the development 
of the nervous system,  and LECAMs,  adhesion molecules 
that carry an NH2-terminal lectin domain, serve as adhesion 
ligands among cells of haematopoietic lineage and endothe- 
lial cells (for reviews, see Olden et al., 1982; Rutishauser and 
Jessell,  1988;  Brandley et al.,  1990;  Dustin and Springer, 
1991). 
In conclusion, nectadrin is a novel cell adhesion molecule 
that is structurally  different from other known cell adhesion 
molecules in that it contains only a very small polypeptide 
core and manifests  an unusual  degree of glycosylation.  It 
may mediate cell adhesion by self-binding and by other mo- 
lecular mechanisms that appear to implicate glycan-glycan 
interactions. 
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